NORCROSS, GA--(Marketwired - Nov 4, 2013) - RayBiotech, Inc. ("RBI") today announced that it is convening the 2013 RayBiotech Global Distributor Conference at its headquarters in suburban Atlanta, Georgia (Norcross). Distributors representing over thirty countries will participate in this year's conference. The conference will focus on the company's short- and long-term strategic direction which will include quality implementation, product portfolio growth and management and addressing new markets. In addition, new products and services launched in 2013 will be covered in detail, and successful international marketing and sales strategies will be explored. The conference will also address laboratory training, with specific distribution partners to be trained and certified to provide RBI services internationally under RBI's Certified Services Provider Program. Leading distribution partners will be recognized for their achievements and excellence in marketing, sales and technical support, particularly as it pertains to their respective geographical territories.
Commenting on the 2013 Global Distributor Conference, RayBiotech's President, Chief Operating Officer and Co-founder, Ms. Rani Huang, stated, "Over the past year, RayBiotech has achieved a number of key accomplishments. These include ISO 13485: 2003 certification for manufacturing quality and the record launch of over 15,000 new products and services. At the same time, our international distribution partners have worked diligently and succeeded immensely in marketing and promoting the RayBiotech portfolio. During this conference we will recap and celebrate the year's accomplishments and outline our strategic direction moving forward. It is with great honor that we host our outstanding international distribution partners at this key conference."
About RayBiotech, Inc.
In 2001 RayBiotech (http://www.raybiotech.com) introduced the first commercially available cytokine antibody array. With a focus on translating scientific knowledge into improved health, RayBiotech continues to pioneer advances in high-throughput platforms for identifying disease mechanisms, screening and validation of biomarkers and identification of drug targets. RayBiotech products are manufactured under GMP and ISO 13485: 2003 compliance and are featured in thousands of publications, including: Nature, Nature Medicine, Cell, Lancet, PNAS and many others. Offering the largest selection of protein arrays, RayBiotech has established a reputation for high quality and innovation in the research community. A spin-off from Emory University, RayBiotech is privately owned, with headquarters in metropolitan Atlanta (Norcross, GA).